The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...
A mid-stage study of a pharmaceutical version of the psychedelic LSD reported the drug might help alleviate anxiety symptoms for up to three months, advancing a potential treatment for the most common ...
ISLAMABAD: At least 80 important medicines are not available in Pakistan, including 25 which have no substitutes, creating serious problems for patients suffering from diabetes, cancer, Alzheimer’s, ...
President Donald Trump also said Zelenskyy can end the war "almost immediately." President Donald Trump returned from Alaska after his high-stakes meeting with Russian President Vladimir Putin, and ...
EAST BRUNSWICK, N.J., July 21, 2025--(BUSINESS WIRE)--Cronus Pharma LLC, a fully integrated research, development, manufacturing, sales and marketing animal health pharmaceutical company, announces ...
A South Florida drug maker recalled 199,584 bottles of three ophthalmic solutions because of a “lack of assurance on sterility.” That’s from FDA alert that the recalls from Apotex’s Weston facility ...
Over-the-counter sleeping tablets relied on by millions could dramatically increase dementia risk, a top US health expert has warned. In a recent post that has been viewed more than three million ...
Objective: This double-blind, multinational study was performed to further evaluate the efficacy of tolterodine, a newbladder-selective antimuscarinic agent, for reducing urge incontinence episodes ...
In middle-aged and older adults with overactive bladder, the drug selected for treatment may influence the risk for dementia. Investigators conducted a nested case-control study using data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results